Back
Oxford Nanopore Technologies PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
63
ONTTF
Oxford Nanopore Technologies PLC
Last Price:
2.04
Seasonality Move:
-29.69%
Sell
37
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.63
Seasonality Move:
29.88%
Buy
63
Oxford Nanopore Technologies PLC (ONTTF)
is a Buy
Is Oxford Nanopore Technologies PLC a Buy, Sell or Hold?
- The current Oxford Nanopore Technologies PLC [ONTTF] share price is $2.05. The Score for ONTTF is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- ONTTF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.64. The Score for ADAP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ONTTF Stock Price Chart
What is Oxford Nanopore Technologies PLC's stock price today?
-
The Oxford Nanopore Technologies PLC share price today is $2.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ONTTF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight buying pressure.
ONTTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 56.11 | Buy |
| Chaikin Money Flow: | 1617 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.67 - 1.99) | Buy |
| Bollinger Bands (100): | (1.64 - 2.06) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 38.79 | Sell |
| Chaikin Money Flow: | 315808 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.62 - 0.76) | Sell |
| Bollinger Bands (100): | (0.73 - 1.15) | Sell |
ONTTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.98 | Buy |
| 20-day SMA: | 1.83 | Buy |
| 50-day SMA: | 1.9 | Buy |
| 200-day SMA: | 1.63 | Buy |
| 8-day EMA: | 1.96 | Buy |
| 20-day EMA: | 1.9 | Buy |
| 50-day EMA: | 1.88 | Buy |
| 200-day EMA: | 1.85 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.67 | Sell |
| 20-day SMA: | 0.67 | Sell |
| 50-day SMA: | 0.76 | Sell |
| 200-day SMA: | 1.08 | Sell |
| 8-day EMA: | 0.66 | Sell |
| 20-day EMA: | 0.69 | Sell |
| 50-day EMA: | 0.77 | Sell |
| 200-day EMA: | 0.96 | Sell |
Oxford Nanopore Technologies PLC Earnings Growth & ONTTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.33 per share.
Oxford Nanopore Technologies PLC Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||